Recent Publications
Prabhu R, Garry RF, Dash S. Small interfering RNA targeted to stem-loop II of the 5' untranslated region effectively inhibits expression of six HCV genotypes.
Virol J. 2006 Nov 27;3:100.
Dash S, Haque S, Joshi V, Prabhu R, Hazari S, Fermin C, Garry R. HCV-hepatocellular carcinoma: new findings and hope for effective treatment.
Microsc Res Tech. 2005 Nov;68(3-4):130-48. Review.
Hazari S, Patil A, Joshi V, Sullivan DE, Fermin CD, Garry RF, Elliott RM, Dash S. Alpha interferon inhibits translation mediated by the internal ribosome entry site of six different hepatitis C virus genotypes.
Bastian FO, McDermott ME, Perry AS, Carver LA, Dash S, Garry RF. J Gen Virol. 2005 Nov;86(Pt 11):3047-53. Safe method for isolation of prion protein and diagnosis of Creutzfeldt-Jakob disease.
J Virol Methods. 2005 Dec;130(1-2):133-9. Epub 2005 Aug 15.
Prabhu R, Vittal P, Yin Q, Flemington E, Garry R, Robichaux WH, Dash S. Small interfering RNA effectively inhibits protein expression and negative strand RNA synthesis from a full-length hepatitis C virus clone.
J Med Virol. 2005 Aug;76(4):511-9.
Pai M, Prabhu R, Panebra A, Nangle S, Haque S, Bastian F, Garry R, Agrawal K, Goodbourn S, Dash S. Activation of interferon-stimulated response element in huh-7 cells replicating hepatitis C virus subgenomic RNA.
Intervirology. 2005 Sep-Oct;48(5):301-11.
Dash S, Prabhu R, Hazari S, Bastian F, Garry R, Zou W, Haque S, Joshi V, Regenstein FG, Thung SN. Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation.
Liver Int. 2005 Jun;25(3):580-94.
Contact info: sdash@tulane.edu